Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma

Autor: Michele Guida, Nicola Bartolomeo, Davide Quaresmini, Pietro Quaglino, Gabriele Madonna, Jacopo Pigozzo, Anna Maria Di Giacomo, Alessandro Marco Minisini, Marco Tucci, Francesco Spagnolo, Marcella Occelli, Laura Ridolfi, Paola Queirolo, Ivana De Risi, Monica Valente, Angela Monica Sciacovelli, Vanna Chiarion Sileni, Paolo Antonio Ascierto, Lucia Stigliano, Sabino Strippoli

Publikováno v: Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-15 (2022)

Abstract Background To evaluate the capability of basal and one-month differed white blood cells (WBC), neutrophil, lymphocyte and platelet values and their ratios (neutrophils-to-lymphocytes ratio, NLR, and platelets-to-lymphocytes ratio, PLR) in pr

Externí odkaz: https://doaj.org/article/6a166c1e64f04ed785a82208677a98c7

Common Diagnostic Challenges in the Histopathologic Diagnosis of Neuroendocrine Lung Tumors: A Case Report

Autor: Monica Valente, Laura Catena, Massimo Milione, Sara Pusceddu, Barbara Formisano, Emilio Bajetta

Publikováno v: Case Reports in Oncology, Vol 3, Iss 2, Pp 202-207 (2010)

Bronchopulmonary neuroendocrine tumors are an uncommon group of neoplasms, accounting for about 20% of all lung carcinomas, arising from stem cells of the bronchial epithelium known as Kulchitsky cells. In the past, these tumors were grouped among be

Externí odkaz: https://doaj.org/article/583b371559ec40a6a412a606b7a9a88e

Data from Primary Analysis and 4-Year Follow-Up of the Phase III NIBIT-M2 Trial in Melanoma Patients With Brain Metastases

Autor: Michele Maio, Mario Mandalà, Diana Giannarelli, Monica Valente, Luana Calabrò, Roberto Camerini, Alessia Covre, Giovanni Amato, Ornella Cutaia, Paolo Marchetti, Massimo Guidoboni, Pietro Quaglino, Michele Guida, Pier Francesco Ferrucci, Michele Del Vecchio, Vanna Chiarion-Sileni, Anna Maria Di Giacomo

Purpose:Phase II trials have shown encouraging activity with ipilimumab plus fotemustine and ipilimumab plus nivolumab in melanoma brain metastases. We report the primary analysis and 4-year follow-up of the NIBIT-M2 study, the first phase III trial

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3352d0e0f6aadeb6a82a401e9a8a1c74
https://doi.org/10.1158/1078-0432.c.6530379.v1

Table S1 from Primary Analysis and 4-Year Follow-Up of the Phase III NIBIT-M2 Trial in Melanoma Patients With Brain Metastases

Autor: Michele Maio, Mario Mandalà, Diana Giannarelli, Monica Valente, Luana Calabrò, Roberto Camerini, Alessia Covre, Giovanni Amato, Ornella Cutaia, Paolo Marchetti, Massimo Guidoboni, Pietro Quaglino, Michele Guida, Pier Francesco Ferrucci, Michele Del Vecchio, Vanna Chiarion-Sileni, Anna Maria Di Giacomo

Maintenance phase treatment exposure

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::798f8514c9effd5d5506bbd9a370dc20
https://doi.org/10.1158/1078-0432.22480134.v1

Personalized Medicine for Patients with Liver, Biliary Tract, and Pancreatic Cancer

Autor: Monica Valente, Alessia Covre, Michele Maio, Anna Maria Di Giacomo

Publikováno v: Hepato-Pancreato-Biliary Malignancies ISBN: 9783030416829
Hepato-Pancreato-Biliary Malignancies ISBN: 9783030374822
Hepato-Pancreato-Biliary Malignancies

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d76995edeba5542ac78ac4f437ffc9d6
https://doi.org/10.1007/978-3-030-41683-6_50